$WSR
Whitestone REIT Stock $wsr

$wsr Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000143774924014401 Filed on May 02, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$37.65M	$37.16M	$35.85M
YoY Change	3.26%	3.66%	5.06%
Cost Of Revenue	$10.93M	$10.59M	$10.79M
YoY Change	-6.33%	-1.92%	-48.72%
Gross Profit	$26.72M	$26.58M	$25.06M
YoY Change	7.77%	6.07%	91.68%
Gross Profit Margin	70.98%	71.51%	69.89%
Selling, General & Admin	$6.552M	$6.180M	$5.084M
YoY Change	26.61%	21.56%	66.74%
% of Gross Profit	24.52%	23.25%	20.29%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$8.542M	$8.822M	$7.846M
YoY Change	1.91%	12.44%	-0.82%
% of Gross Profit	31.97%	33.19%	31.31%
Operating Expenses	$15.07M	$14.98M	$12.93M
YoY Change	11.36%	15.85%	113.3%
Operating Profit	$11.65M	$11.60M	$12.13M
YoY Change	3.45%	-4.37%	73.0%
Interest Expense	-$8.784M	-$8.539M	$7.903M
YoY Change	-206.34%	-208.05%	30.39%
% of Operating Profit	-75.42%	-73.63%	65.17%
Other Income/Expense, Net	-$8.931M	-$1.986M	-$7.889M
YoY Change	-754.29%	-74.83%	30.14%
Pretax Income	$2.716M	$9.583M	$4.238M
YoY Change	-78.49%	126.12%	-41.87%
Income Tax	$90.00K	$119.0K	$119.0K
% Of Pretax Income	3.31%	1.24%	2.81%
Net Earnings	$2.592M	$9.340M	$3.847M
YoY Change	-77.07%	142.79%	-45.65%
Net Earnings / Revenue	6.89%	25.13%	10.73%
Basic Earnings Per Share	$0.05	$0.19	$0.08
Diluted Earnings Per Share	$0.05	$0.18	$0.08
COMMON SHARES
Basic Shares Outstanding	49.96M	49.96M	49.42M
Diluted Shares Outstanding	51.12M	51.11M	50.16M

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.231M	$6.215M	$3.479M
YoY Change	10.39%	78.64%	-68.76%
Cash & Equivalents	$3.231M	$6.215M	$3.479M
Short-Term Investments
Other Short-Term Assets	$11.99M	$11.19M	$7.309M
YoY Change	1.16%	53.15%	118.83%
Inventory
Prepaid Expenses
Receivables	$3.714M	$2.950M	$3.158M
Other Receivables	$60.38M	$61.27M	$25.14M
Total Short-Term Assets	$79.31M	$81.63M	$39.08M
YoY Change	83.42%	108.86%	-0.86%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.029B	$1.009B	$997.6M
YoY Change	1.19%	1.1%	-0.51%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$0.00	$0.00	$34.61M
YoY Change	-100.0%	-100.0%	-0.75%
Other Assets	$14.57M	$14.20M	$12.61M
YoY Change	12.25%	12.65%	46.95%
Total Long-Term Assets	$1.061B	$1.040B	$1.055B
YoY Change	-2.26%	-1.4%	-0.07%
TOTAL ASSETS
Total Short-Term Assets	$79.31M	$81.63M	$39.08M
Total Long-Term Assets	$1.061B	$1.040B	$1.055B
Total Assets	$1.140B	$1.122B	$1.094B
YoY Change	1.02%	2.54%	-0.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$33.15M	$32.02M	$28.20M
YoY Change	8.78%	13.55%	-8.44%
Accrued Expenses	$75.00K	$112.0K	$111.0K
YoY Change	-23.47%	0.9%	-47.14%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$44.24M	$45.15M
YoY Change
Total Short-Term Liabilities	$94.31M	$48.72M	$44.23M
YoY Change	102.5%	10.17%	-4.48%
LONG-TERM LIABILITIES
Long-Term Debt	$622.2M	$645.7M	$631.1M
YoY Change	-4.38%	2.31%	-1.98%
Other Long-Term Liabilities		$0.00	$0.00
YoY Change
Total Long-Term Liabilities	$622.2M	$645.7M	$631.1M
YoY Change	-4.38%	2.31%	-1.98%
TOTAL LIABILITIES
Total Short-Term Liabilities	$94.31M	$48.72M	$44.23M
Total Long-Term Liabilities	$622.2M	$645.7M	$631.1M
Total Liabilities	$716.5M	$700.0M	$675.4M
YoY Change	2.75%	3.65%	-2.15%
SHAREHOLDERS EQUITY
Retained Earnings	-$217.4M	-$213.8M	-$214.5M
YoY Change	3.98%	-0.3%
Common Stock	$50.00K	$50.00K	$49.00K
YoY Change	0.0%	2.04%	-99.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$418.3M	$421.6M	$412.6M
YoY Change
Total Liabilities & Shareholders Equity	$1.140B	$1.122B	$1.094B
YoY Change	1.02%	2.54%	-0.1%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	$2.592M	$9.340M	$3.847M
YoY Change	-77.07%	142.79%	-45.65%
Depreciation, Depletion And Amortization	$8.542M	$8.822M	$7.846M
YoY Change	1.91%	12.44%	-0.82%
Cash From Operating Activities	$12.26M	$11.52M	$4.915M
YoY Change	-27.02%	134.47%	0.0%
INVESTING ACTIVITIES
Capital Expenditures	$28.44M	$30.25M	$3.529M
YoY Change	-35.58%	757.04%	-205.06%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$25.66M
YoY Change	-100.0%
Cash From Investing Activities	-$28.44M	-$4.584M	-$3.529M
YoY Change	-7.36%	29.9%	5.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	13.20M	-5.365M	-$4.069M
YoY Change	-0.61%	31.85%	-34.52%
NET CHANGE
Cash From Operating Activities	12.26M	11.52M	$4.915M
Cash From Investing Activities	-28.44M	-4.584M	-$3.529M
Cash From Financing Activities	13.20M	-5.365M	-$4.069M
Net Change In Cash	-2.984M	1.575M	-$2.683M
YoY Change	378.97%	-158.7%	-42.4%
FREE CASH FLOW
Cash From Operating Activities	$12.26M	$11.52M	$4.915M
Capital Expenditures	$28.44M	$30.25M	$3.529M
Free Cash Flow	-$16.18M	-$18.72M	$1.386M
YoY Change	-40.83%	-1450.72%	-83.25%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49958896
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49958896
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49610831
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49610831
CY2024Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.12
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.12
CY2024Q1	wstr	Conversion Ratio For Class Common Stock To Op Unit ConversionRatioForClassCommonStockToOPUnit	1
CY2024Q1	us-gaap	Debt Instrument Variable Interest Rate Type Extensible Enumeration DebtInstrumentVariableInterestRateTypeExtensibleEnumeration	http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember
CY2023	us-gaap	Debt Instrument Variable Interest Rate Type Extensible Enumeration DebtInstrumentVariableInterestRateTypeExtensibleEnumeration	http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember
CY2023Q1	us-gaap	Investment Variable Interest Rate Type Extensible Enumeration InvestmentVariableInterestRateTypeExtensibleEnumeration	http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember
CY2024Q1	us-gaap	Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2024#InterestExpense
CY2023Q1	us-gaap	Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2024#InterestExpense
CY2024Q1	wstr	Conversion Ratio For Class Common Stock To Op Unit ConversionRatioForClassCommonStockToOPUnit	1
CY2022Q4	wstr	Number Of Independent Trustees NumberOfIndependentTrustees	5	pure
CY2022Q4	wstr	Number Of Trustee Emeritus NumberOfTrusteeEmeritus	1	pure
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-34855
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	76-0594970
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	2600 South Gessner, Suite 500
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77063
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Houston
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2024Q1	dei	City Area Code CityAreaCode	713
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	827-9595
CY2024Q1	dei	Security12b Title Security12bTitle	Common Shares of Beneficial Interest, par value $0.001 per share
CY2024Q1	dei	Trading Symbol TradingSymbol	WSR
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	49959638
CY2024Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	1230936000	usd
CY2023Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	1221466000	usd
CY2024Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	232867000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	229767000	usd
CY2024Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	998069000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	991699000	usd
CY2024Q1	us-gaap	Equity Method Investments EquityMethodInvestments	0	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	31671000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6215000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4572000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	68000	usd
CY2024Q1	us-gaap	Deposit Assets DepositAssets	17272000	usd
CY2023Q4	us-gaap	Deposit Assets DepositAssets	24148000	usd
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	31055000	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	30592000	usd
CY2024Q1	us-gaap	Other Receivables OtherReceivables	31643000	usd
CY2023Q4	us-gaap	Other Receivables OtherReceivables	0	usd
CY2024Q1	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	14200000	usd
CY2023Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	13783000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	11302000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	4765000	usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	10406000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	10428000	usd
CY2024Q1	us-gaap	Assets Assets	1121684000	usd
CY2023Q4	us-gaap	Assets Assets	1113239000	usd
CY2024Q1	us-gaap	Notes Payable NotesPayable	644981000	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	640172000	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	32133000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	36513000	usd
CY2024Q1	us-gaap	Security Deposit Liability SecurityDepositLiability	8799000	usd
CY2023Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	8614000	usd
CY2024Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	6215000	usd
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	6025000	usd
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	716000	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	721000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	694421000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	693622000	usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	50000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	50000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	627876000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	628079000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-213798000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-216963000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	7517000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2576000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	421645000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	413742000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	5618000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	5875000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	427263000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	419617000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1121684000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1113239000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	108000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	109000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	112000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	112000	usd
CY2024Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	36741000	usd
CY2023Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	35497000	usd
CY2024Q1	us-gaap	Other Income OtherIncome	423000	usd
CY2023Q1	us-gaap	Other Income OtherIncome	354000	usd
CY2024Q1	us-gaap	Revenues Revenues	37164000	usd
CY2023Q1	us-gaap	Revenues Revenues	35851000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	8800000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7846000	usd
CY2024Q1	us-gaap	Cost Of Property Repairs And Maintenance CostOfPropertyRepairsAndMaintenance	6349000	usd
CY2023Q1	us-gaap	Cost Of Property Repairs And Maintenance CostOfPropertyRepairsAndMaintenance	6086000	usd
CY2024Q1	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	4238000	usd
CY2023Q1	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	4708000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6180000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5084000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	25567000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	23724000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	8519000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	7903000	usd
CY2024Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	6525000	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-0	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-0	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-6000	usd
CY2024Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	8000	usd
CY2023Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	20000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1986000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7889000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	9611000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	4238000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-28000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-218000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	119000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	119000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	9464000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	3901000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	124000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	54000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	9340000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	3847000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49940000
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49424000
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51112000
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50160000
CY2024Q1	us-gaap	Profit Loss ProfitLoss	9464000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	3901000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	5007000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-4587000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	14471000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-686000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	124000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	54000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	66000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-64000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	14281000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-676000	usd
CY2024Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	26864000	usd
CY2023Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	25740000	usd
CY2024Q1	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	10477000	usd
CY2023Q1	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	10081000	usd
CY2024Q1	us-gaap	Net Investment In Lease Credit Loss Expense Reversal NetInvestmentInLeaseCreditLossExpenseReversal	600000	usd
CY2023Q1	us-gaap	Net Investment In Lease Credit Loss Expense Reversal NetInvestmentInLeaseCreditLossExpenseReversal	324000	usd
CY2024Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	36741000	usd
CY2023Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	35497000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	419617000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	0	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	23000	usd
CY2024Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1442000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	861000	usd
CY2024Q1	us-gaap	Dividends Dividends	6267000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	5007000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	9464000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	427263000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	424454000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	17000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	755000	usd
CY2023Q1	us-gaap	Dividends Dividends	6014000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-4587000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	3901000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	418526000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	9464000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	3901000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8800000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7846000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	265000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	277000	usd
CY2024Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	6525000	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-0	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-0	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-6000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	600000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	324000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	861000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	755000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-28000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-218000	usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	22000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	29000	usd
CY2024Q1	us-gaap	Increase Decrease In Deposits Outstanding IncreaseDecreaseInDepositsOutstanding	-6876000	usd
CY2023Q1	us-gaap	Increase Decrease In Deposits Outstanding IncreaseDecreaseInDepositsOutstanding	-2796000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	1063000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	1646000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	9000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	26000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	817000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	521000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-997000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1117000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-8160000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-7843000	usd
CY2024Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	0	usd
CY2023Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	1000	usd
CY2024Q1	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	185000	usd
CY2023Q1	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-85000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	11524000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4915000	usd
CY2024Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	27204000	usd
CY2023Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	-0	usd
CY2024Q1	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	3041000	usd
CY2023Q1	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	3529000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	25661000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4584000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3529000	usd
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	5969000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	5913000	usd
CY2024Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	80000	usd
CY2023Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	83000	usd
CY2024Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	23000000	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	9500000	usd
CY2024Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	20869000	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	7571000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1442000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-0	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	5000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5365000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4069000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1575000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2683000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4640000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6355000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6215000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3672000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	8160000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	7610000	usd
CY2024Q1	wstr	Disposal Of Fully Depreciated Real Estate DisposalOfFullyDepreciatedRealEstate	29000	usd
CY2023Q1	wstr	Disposal Of Fully Depreciated Real Estate DisposalOfFullyDepreciatedRealEstate	864000	usd
CY2024Q1	wstr	Dollar Amount Of Insurance Premiums Financed During Reporting Period DollarAmountOfInsurancePremiumsFinancedDuringReportingPeriod	2638000	usd
CY2023Q1	wstr	Dollar Amount Of Insurance Premiums Financed During Reporting Period DollarAmountOfInsurancePremiumsFinancedDuringReportingPeriod	3002000	usd
CY2024Q1	us-gaap	Stock Issued1 StockIssued1	23000	usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1	17000	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Cash Flow Hedging Instruments UnrealizedGainLossOnCashFlowHedgingInstruments	5007000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Cash Flow Hedging Instruments UnrealizedGainLossOnCashFlowHedgingInstruments	-4587000	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1962000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
CY2024Q1	wstr	Receivable From Redemption Of Partnership ReceivableFromRedemptionOfPartnership	31643000	usd
CY2023Q1	wstr	Receivable From Redemption Of Partnership ReceivableFromRedemptionOfPartnership	0	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6215000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3479000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	193000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6215000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3672000	usd
CY2004Q3	wstr	Reorganization And Conversion Number Of Common Shares ReorganizationAndConversionNumberOfCommonShares	1.42857	pure
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"><i>Use of Estimates.</i> The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates that we use include the estimated fair values of properties acquired, the estimated useful lives for depreciable and amortizable assets and costs, the grant date fair value of common share units included in share-based compensation expense, the estimated allowance for doubtful accounts, the estimated fair value of interest rate swaps, the estimates supporting our impairment analysis for the carrying values of our real estate assets, and the estimates made regarding Pillarstone REIT Operating Partnership LP’s financial condition and results of operations. Actual results could differ from those estimates. </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"></p>
CY2024Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"><i>Reclassifications.</i> We have reclassified certain prior period amounts in the accompanying consolidated financial statements in order to be consistent with the current period presentation. These reclassifications had <em style="font: inherit;">no</em> effect on net income, total assets, total liabilities or equity.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"></p>
CY2024Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	134000	usd
CY2024Q1	wstr	Real Estate Taxes Capitalized RealEstateTaxesCapitalized	61000	usd
CY2023Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	134000	usd
CY2023Q1	wstr	Real Estate Taxes Capitalized RealEstateTaxesCapitalized	73000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	936000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	829000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	13900000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	13600000	usd
CY2024Q1	us-gaap	Net Investment In Lease Credit Loss Expense Reversal NetInvestmentInLeaseCreditLossExpenseReversal	600000	usd
CY2023Q1	us-gaap	Net Investment In Lease Credit Loss Expense Reversal NetInvestmentInLeaseCreditLossExpenseReversal	300000	usd
CY2024Q1	wstr	Accounts Receivable Credit Loss Expense Reversal Number Of Tenants Covid19 AccountsReceivableCreditLossExpenseReversalNumberOfTenantsCovid19	19	pure
CY2024Q1	wstr	Straight Line Rent Adjustments Covid19 StraightLineRentAdjustmentsCovid19	20000.00	usd
CY2024Q1	wstr	Accounts Receivable Credit Loss Expense Reversal Covid19 AccountsReceivableCreditLossExpenseReversalCovid19	200000	usd
CY2023Q1	wstr	Accounts Receivable Credit Loss Expense Reversal Number Of Tenants Covid19 AccountsReceivableCreditLossExpenseReversalNumberOfTenantsCovid19	71	pure
CY2023Q1	wstr	Straight Line Rent Adjustments Covid19 StraightLineRentAdjustmentsCovid19	200000	usd
CY2023Q1	wstr	Accounts Receivable Credit Loss Expense Reversal Covid19 AccountsReceivableCreditLossExpenseReversalCovid19	200000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	74197000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	88159000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	73653000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	60780000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	46937000	usd
CY2024Q1	wstr	Lessor Operating Lease Payment To Be Received After Year Four LessorOperatingLeasePaymentToBeReceivedAfterYearFour	136262000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	479988000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	62000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	46000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	42000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	63000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	10000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	64000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	65000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	66000	usd
CY2024Q1	wstr	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	0	usd
CY2024Q1	wstr	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	2709000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	118000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	3013000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	6000	usd
CY2024Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	2297000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	112000	usd
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	716000	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	19000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	33000	usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	22000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	29000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M18D
CY2024Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P98Y
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.047	pure
CY2024Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.06	pure
CY2023Q4	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	1168000	usd
CY2024Q1	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	14200000	usd
CY2023Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	13783000	usd
CY2024Q1	wstr	Tenant Receivables TenantReceivables	16869000	usd
CY2023Q4	wstr	Tenant Receivables TenantReceivables	16287000	usd
CY2024Q1	wstr	Accrued Rents And Other Recoveries AccruedRentsAndOtherRecoveries	27126000	usd
CY2023Q4	wstr	Accrued Rents And Other Recoveries AccruedRentsAndOtherRecoveries	26751000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	13919000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	13570000	usd
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	31055000	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	30592000	usd
CY2024Q1	us-gaap	Deferred Costs Leasing Gross DeferredCostsLeasingGross	20335000	usd
CY2023Q4	us-gaap	Deferred Costs Leasing Gross DeferredCostsLeasingGross	19462000	usd
CY2024Q1	us-gaap	Other Deferred Costs Gross OtherDeferredCostsGross	335000	usd
CY2023Q4	us-gaap	Other Deferred Costs Gross OtherDeferredCostsGross	356000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	4205000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	4149000	usd
CY2024Q1	wstr	Deferred Costs Gross DeferredCostsGross	24875000	usd
CY2023Q4	wstr	Deferred Costs Gross DeferredCostsGross	23967000	usd
CY2024Q1	us-gaap	Deferred Costs Leasing Accumulated Amortization DeferredCostsLeasingAccumulatedAmortization	9020000	usd
CY2023Q4	us-gaap	Deferred Costs Leasing Accumulated Amortization DeferredCostsLeasingAccumulatedAmortization	8744000	usd
CY2024Q1	us-gaap	Accumulated Amortization Of Other Deferred Costs AccumulatedAmortizationOfOtherDeferredCosts	262000	usd
CY2023Q4	us-gaap	Accumulated Amortization Of Other Deferred Costs AccumulatedAmortizationOfOtherDeferredCosts	272000	usd
CY2024Q1	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	1393000	usd
CY2024Q1	us-gaap	Equity Method Investments EquityMethodInvestments	0	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	31671000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	9340000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3847000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49940000
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49424000
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1172000
CY2024Q1	wstr	Equity Method Investment Difference Between Carrying Amount And Underlying Equity Amortization EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquityAmortization	7000	usd
CY2023Q1	wstr	Equity Method Investment Difference Between Carrying Amount And Underlying Equity Amortization EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquityAmortization	27000	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	645317000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	640549000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	336000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	377000	usd
CY2024Q1	us-gaap	Secured Debt SecuredDebt	123110000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	45150000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	17596000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	186143000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	97143000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	282143000	usd
CY2024Q1	wstr	Long Term Debt Maturities Repayments Of Principal After Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour	17142000	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	645317000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	9464000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	3901000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	124000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	54000	usd
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	736000
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51112000
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50160000
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2024Q1	wstr	Applicable Tax Rate Used To Determine State Margin Tax ApplicableTaxRateUsedToDetermineStateMarginTax	0.0075	pure
CY2024Q1	wstr	Margin Tax Provision Recognized MarginTaxProvisionRecognized	120000	usd
CY2023Q1	wstr	Margin Tax Provision Recognized MarginTaxProvisionRecognized	119000	usd
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	wstr	Issuance And Sale Of Securities Maximum IssuanceAndSaleOfSecuritiesMaximum	500000000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	0
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	210400
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	877000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	480184
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	9.3
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	231600
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	1841000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	360334
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	11.61
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	519003
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	3442000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	936000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	829000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	24134
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	24134
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	12.44

Files In Submission

Name	View Source	Status
0001437749-24-014401-index-headers.html	Edgar Link	pending
0001437749-24-014401-index.html	Edgar Link	pending
0001437749-24-014401.txt	Edgar Link	pending
0001437749-24-014401-xbrl.zip	Edgar Link	pending
ex_648702.htm	Edgar Link	pending
ex_648703.htm	Edgar Link	pending
ex_648704.htm	Edgar Link	pending
ex_648705.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
wstr-20240331.xsd	Edgar Link	pending
wstr20240331_10q.htm	Edgar Link	pending
wstr-20240331_lab.xml	Edgar Link	unprocessable
wstr-20240331_pre.xml	Edgar Link	unprocessable
wstr20240331_10q_htm.xml	Edgar Link	completed
wstr-20240331_cal.xml	Edgar Link	unprocessable
wstr-20240331_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$WSR
Whitestone REIT Stock $wsr

2024 Q2 Form 10-Q Financial Statement

#000143774924014401 Filed on May 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WSR Whitestone REIT Stock $wsr

2024 Q2 Form 10-Q Financial Statement

#000143774924014401 Filed on May 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WSR
Whitestone REIT Stock $wsr